Nike Says Business Will Get Worse Before It Gets Better. The Stock Is Sliding

Nike projected fiscal-year revenue will fall by high-single digits, materially worse than Wall Street's expectation for a low-single-digit decline, and guided adjusted EPS to $1.15-$1.35. Fiscal first-quarter sales fell 4% year over year to $11.21B, missing the $11.33B consensus amid weakness in China and EMEA, although EPS of $0.48 exceeded the $0.44 estimate. Shares fell 6% in after-hours trading as the outlook undermined expectations for a near-term turnaround.

Analysis

The key market implication is a deeper channel reset rather than a one-quarter demand miss. A high-single-digit top-line contraction against a largely fixed demand-creation and corporate-cost base makes operating deleverage the near-term earnings risk; even successful inventory clean-up can be margin-dilutive if it requires heavier markdowns and wholesale concessions. The larger concern is that product-transition spending may depress earnings before new running, performance and lifestyle franchises produce sufficient sell-through, extending the valuation debate from a cyclical recovery to a multi-year brand-rebuild multiple.

Competitive share loss is likely to be most visible in premium running and fashion-led footwear, where ONON, DECK, LULU and adidas (ADDYY) have stronger current product momentum and less need to discount legacy franchises. Retailers may use weaker Nike turns to reallocate shelf space toward these brands, creating a second-order problem: lost wholesale placement is harder to recover than a temporary direct-to-consumer sales shortfall. China remains the central swing factor because local brands can compete aggressively on price and cultural relevance; a weaker renminbi or renewed consumer caution would make a recovery harder even if Western demand stabilizes.

The investor-day is a 1-3 month catalyst, but only credible SKU rationalization, wholesale-order stabilization and a dated gross-margin bridge can change the narrative. Consensus may underestimate how much bad news is already embedded after the drawdown, yet management must demonstrate that revenue pressure is intentional channel repair rather than persistent consumer substitution. Thesis falsification for a bearish stance would be evidence of sequential improvement in North America/EMEA wholesale orders, normalized promotional intensity, and a margin outlook that holds despite lower revenue.

Key Decisions for Investors

• Maintain or initiate an underweight/short NKE into the investor day, sized modestly given depressed sentiment; target a further 10-15% relative underperformance versus XLY if management cannot provide quarterly milestones for sales and gross-margin recovery. Cover if forward EPS expectations reset below management's range and the stock holds relative strength, or if wholesale-order commentary improves materially.
• Pair trade for the next 3-6 months: long ONON or DECK / short NKE in equal dollar beta-adjusted exposure. The thesis is shelf-space and consumer-wallet reallocation rather than a broad discretionary call; exit if ONON/DECK report slowing wholesale growth or Nike reports sequential acceleration in full-price sell-through.
• Avoid buying NKE solely on the post-guidance decline until there is independent evidence that inventory, markdown rates and wholesale cancellations have bottomed. Set an alert for investor-day disclosure of inventory turns, China transaction trends and expected gross-margin cadence; without these, the turnaround timeline remains too unconstrained for a high-conviction long.
• For accounts requiring defined risk, consider a 3-6 month NKE put spread rather than outright puts after any investor-day relief rally of roughly 8-12%. The reward is renewed multiple compression if the recovery is pushed out again; the principal risk is a credible restructuring plan triggering a sharp short-covering rally.